CareRx Corporation
CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical…
1D
-2.7%
1W
-2.4%
1M
-2.1%
6M
-15.6%
YTD
-16.2%
1Y
-10.1%
2Y
+48.8%
5Y
-41.5%
10Y
-57.9%
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~38% weaker price swings than usual
Pattern detected by the Market Jury detector vrange-breakout-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Range breakout
BullishThe price has broken out of a longer sideways range (support and resistance) to the upside or downside. In technical analysis, this is read as a signal that a new trend is starting in the breakout direction.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
P/E
7.46
P/B
1.85
EV/EBITDA
9.08
RETURN ON EQUITY
0.3%
NET MARGIN
0.4%
DEBT/EQUITY
0.7
DIVIDEND YIELD
2.6%
AS OF
30/06/2026
FREE FLOAT
89.0%
FLOAT SHARES
56,458,992
AVG. DAILY VOLUME (30D)
46,008
CareRx Corporation is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in Canada.
The CEO is Puneet Khanna, the company employs around 1,483 people.
The IPO was on 13/02/2008; the stock trades on TSX under the ticker CRRX.TO.
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly -38% stronger than usual.
Yes. The last dividend was CA$0.02 per share, ex-date 15/09/2026, paid on 08/10/2026.
The dividend yield is 2.6% (as of 30/06/2026).
Comparable stocks include HCA Healthcare, Fresenius, Tenet Healthcare, DaVita, Universal Health Services, Fresenius Medical Care, Hims & Hers Health and LifeStance Health Group.
Clicking "Analyze stock" lets five strategies assess CareRx against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.